TEVA PHARMACEUTICAL INDUSTRIES LIMITED Other Non-Current Liabilities
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Other Non-Current Liabilities of $3.79 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-07-29
- 2026-06-30: Other Liabilities, Noncurrent $3.79B.
- 2026-03-31: Other Liabilities, Noncurrent $3.71B.
- 2025-12-31: Other Liabilities, Noncurrent $3.81B.
- 2025-09-30: Other Liabilities, Noncurrent $3.66B.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $3.79B 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $3.71B 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $3.81B 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $3.66B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $3.94B 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $4.01B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $4.03B 10-K · filed 2026-02-03 | |
| 2024-09-30 | $4.34B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $4.36B 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $3.99B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $4.02B 10-K · filed 2025-02-05 | |
| 2023-09-30 | $3.95B 10-Q · filed 2024-11-06 | $3.82B 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.09B 10-Q · filed 2024-07-31 | $3.97B 10-Q · filed 2023-08-02 |
| 2023-03-31 | $3.98B 10-K · filed 2024-02-12 | $3.87B 10-Q · filed 2023-05-10 |
| 2022-12-31 | $3.94B 10-K · filed 2024-02-12 | $3.85B 10-K · filed 2023-02-10 |
| 2022-09-30 | $3.86B 10-K · filed 2024-02-12 | $3.85B 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.86B 10-K · filed 2024-02-12 | $3.84B 10-Q · filed 2022-07-27 |
| 2022-03-31 | $3.29B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $2.58B 10-K · filed 2023-02-10 | |
| 2021-09-30 | $2.20B 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $2.21B 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $2.22B 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $2.24B 10-K · filed 2022-02-09 | |
| 2020-09-30 | $2.18B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.41B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $2.62B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.64B 10-K · filed 2021-02-10 | |
| 2019-09-30 | $2.55B 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.64B 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $1.67B 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $1.73B 10-K · filed 2020-02-21 | |
| 2018-09-30 | $1.80B 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $1.81B 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $1.88B 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $1.84B 10-K · filed 2019-02-19 | |
| 2017-09-30 | $1.96B 6-K · filed 2017-11-02 | |
| 2017-06-30 | $2.04B 6-K · filed 2017-08-03 | |
| 2017-03-31 | $1.64B 6-K · filed 2017-05-11 | |
| 2016-12-31 | $1.64B 10-K · filed 2018-02-12 | |
| 2016-09-30 | $1.39B 6-K · filed 2016-11-15 | |
| 2016-06-30 | $1.35B 6-K · filed 2016-08-04 | |
| 2016-03-31 | $1.31B 6-K · filed 2016-05-09 | |
| 2015-12-31 | $1.20B 20-F · filed 2017-02-15 | |
| 2015-09-30 | $1.32B 6-K · filed 2015-10-29 | |
| 2015-06-30 | $1.34B 6-K · filed 2015-07-30 | |
| 2015-03-31 | $1.37B 6-K · filed 2015-04-30 | |
| 2014-12-31 | $1.11B 20-F · filed 2016-02-11 | |
| 2014-09-30 | $1.22B 6-K · filed 2014-10-30 | |
| 2014-06-30 | $1.00B 6-K · filed 2014-07-31 | |
| 2014-03-31 | $960.00M 6-K · filed 2014-05-02 | |
| 2013-12-31 | $1.27B 20-F · filed 2015-02-09 | |
| 2013-09-30 | $1.82B 6-K · filed 2013-10-31 | |
| 2013-06-30 | $1.72B 6-K · filed 2013-08-01 | |
| 2013-03-31 | $1.32B 6-K · filed 2013-05-02 | |
| 2012-12-31 | $1.29B 20-F · filed 2014-02-10 | |
| 2012-09-30 | $1.28B 6-K · filed 2012-11-01 | |
| 2012-06-30 | $1.32B 6-K · filed 2012-08-02 | |
| 2012-03-31 | $1.28B 6-K · filed 2012-05-09 | |
| 2011-12-31 | $1.28B 20-F · filed 2013-02-12 | $1.11B 20-F · filed 2012-02-17 |
| 2011-09-30 | $828.00M 6-K · filed 2011-11-02 | |
| 2011-06-30 | $830.00M 6-K · filed 2011-07-28 | |
| 2011-03-31 | $809.00M 6-K · filed 2011-05-11 | |
| 2010-12-31 | $998.00M 20-F · filed 2012-02-17 | $777.00M 20-F · filed 2011-02-15 |
| 2009-12-31 | $727.00M 20-F · filed 2011-02-15 |